Last kr273.10 DKK
Change Today +2.40 / 0.89%
Volume 269.0K
NZYMB On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Copenhagen
Frankfurt
As of 11:01 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

novozymes a/s-b shares (NZYMB) Snapshot

Open
kr271.90
Previous Close
kr270.70
Day High
kr273.70
Day Low
kr271.50
52 Week High
07/3/14 - kr280.00
52 Week Low
07/31/13 - kr192.10
Market Cap
87.3B
Average Volume 10 Days
356.5K
EPS TTM
kr7.57
Shares Outstanding
266.0M
EX-Date
02/27/14
P/E TM
36.1x
Dividend
kr2.50
Dividend Yield
0.92%
Current Stock Chart for NOVOZYMES A/S-B SHARES (NZYMB)

Related News

No related news articles were found.

novozymes a/s-b shares (NZYMB) Related Businessweek News

No Related Businessweek News Found

novozymes a/s-b shares (NZYMB) Details

Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. The company offers solutions for the agriculture industry, including enzymes to enhance digestibility and nutritional value of animal feed; microbial solutions to maintain water quality, limit risks of disease, and enhance yields in aquaculture; and microbial-based biofertility, biocontrol, and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; recombinant products and technologies to the medical device and drug delivery market; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and microbial solutions for biological wastewater treatment. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

6,156 Employees
Last Reported Date: 04/24/14
Founded in 1925

novozymes a/s-b shares (NZYMB) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: kr8.3M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: kr5.2M
Executive Vice President of Supply Operations
Total Annual Compensation: kr5.2M
CSO and Executive Vice President of Research ...
Total Annual Compensation: kr5.0M
Executive Vice President of Business Operatio...
Total Annual Compensation: kr3.6M
Compensation as of Fiscal Year 2013.

novozymes a/s-b shares (NZYMB) Key Developments

Novozymes A/S(CPSE:NZYM B) added to OMX Nordic 40 Index

Novozymes A/S will be added to the OMX Nordic 40 Index.

Earth Alive Signs Patent Co-Ownership Agreement With Novozymes

Earth Alive Clean Technologies announced that it has signed a patent co-ownership agreement with Novozymes. The patent co-ownership agreement refers to an innovative dust control technology developed by Earth Alive and Novozymes which uses microbial technology to control airborne dust particles that emanate from the soil. The terms of the co-ownership agreement will allow both companies to begin exploring avenues of joint collaboration for the worldwide deployment and commercialisation of this new technology. Dust contamination is an ever growing global environmental pollution challenge occurring in various industries, and the innovative use of microbial technology in the dust control industry will provide a safe, effective and environmentally sustainable method to reduce harmful dust emissions, while eliminating the need to use the toxic chemicals traditionally used in the dust control industry.

Novozymes A/S Presents at World Congress on Industrial Biotechnology, May-12-2014

Novozymes A/S Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr273.10 DKK +2.40

NZYMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cambrex Corp $21.70 USD -0.13
Codexis Inc $1.45 USD +0.03
Dyadic International Inc $1.59 USD -0.08
Koninklijke DSM NV €50.24 EUR -0.30
Lonza Group AG SFr.93.15 CHF -1.45
View Industry Companies
 

Industry Analysis

NZYMB

Industry Average

Valuation NZYMB Industry Range
Price/Earnings 36.1x
Price/Sales 7.1x
Price/Book 8.0x
Price/Cash Flow 30.2x
TEV/Sales 5.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit www.novozymes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.